Connect with us

Healthcare

Church of Jesus Christ of Latter-day Saints urges its members to get vaccinated

Published

on

Screen Shot 2021 08 12 at 4.47.16 PM scaled

[brid autoplay=”true” video=”698512″ player=”23886″ title=”moderna%20looking%20good%206%20million%20doses” duration=”24″ description=”undefined” uploaddate=”2021-01-04″ thumbnailurl=”//cdn.brid.tv/live/partners/18168/thumb/698512_t_1609803251.png” contentUrl=”//cdn.brid.tv/live/partners/18168/sd/698512.mp4″]


By Jenny Goldsberry

The Church of Jesus Christ of Latter-day Saints, otherwise known as the Mormon church, urged its congregation to get vaccinated for COVID-19 and wear masks. The Church addressed its Thursday statement to all its global members. The First Presidency, consisting of the prophet and his two counselors signed the letter. All three have received the vaccine and broadcasted the process on social media.


“We find ourselves fighting a war against the ravages of COVID-19 and its variants, an unrelenting pandemic,” the statement begins. “We want to do all we can to limit the spread of these viruses. We know that protection from the diseases they cause can only be achieved by immunizing a very high percentage of the population.” The Church’s prophet, Russel M. Nelson, was a career heart surgeon until 1984.

“To limit exposure to these viruses, we urge the use of face masks in public meetings whenever social distancing is not possible,” the statement read. “To provide personal protection from such severe infections, we urge individuals to be vaccinated. Available vaccines have proven to be both safe and effective.”

Finally, they wrote of their hope to end the pandemic. “We can win this war if everyone will follow the wise and thoughtful recommendations of medical experts and government leaders,” they wrote. “Please know of our sincere love and great concern for all of God’s children.”

You can follow Jenny Goldsberry on Twitter @jennyjournalism.

You may like

Continue Reading

China

FDA will work with China to import cancer drugs due to U.S. shortages

Published

on

FinalFDAshutterstock 1044596995

Earlier this week the United States Food and Drug Administration (FDA) announced it will be working to import chemotherapy drugs from, of all places, China. The drug, called Cisplatin, is to help “ramp up supply amidst rampant drug shortages in the U.S.” reports Foreign Desk News.

Foreign Desk News writes:

Cisplatin comes from drugmaker Qilu Pharmaceutical, which is marketed and produced in China but has not been approved by the FDA. According to a May 24 letter, Qilu will work with the Canadian-based drug company Apotex to import and distribute the medication, which will come in 50-milligram vials with Chinese labels.

“The FDA is responding to yet another generic drug shortage,” said Edmund F. Haislmaier, an expert in healthcare policy and markets at The Heritage Foundation. “The underlying cause of those shortages is that generic drugs have become low-margin commodity products,” he added.

Last week on Twitter, FDA commissioner Dr. Robert Califf said the partnership with Qilu Pharmaceutical is temporary but will provide patients with a potentially life-extending drug.

“The public should rest assured that we will continue all efforts within our authority to help the industry that manufactures and distributes these drugs meet all patient needs for the oncology drugs impacted by shortages,” Califf said.

Foreign Desk News adds:

The latest move by the FDA is sure to spark concern and debate in Congress, as lawmakers in the House and Senate have called on the Biden administration to de-couple the U.S. economy from the Chinese markets, given Beijing’s aggressive push to expand in the South-China Sea and eventually take over the island state of Taiwan. China has also spread illegal and dangerous synthetic opioids and fentanyl drugs across the U.S. southern border, resulting in the devastating deaths of many Americans.

 

You may like

Continue Reading
Advertisement
-->

Trending Now

Advertisement
-->

Trending